211 related articles for article (PubMed ID: 30797279)
1. Achieving TB elimination in India: The role of latent TB management.
Sharma N; Basu S; Chopra KK
Indian J Tuberc; 2019 Jan; 66(1):30-33. PubMed ID: 30797279
[TBL] [Abstract][Full Text] [Related]
2. Ethical issues in expanding latent TB management in high burden countries.
Basu S; Sharma N; Mase S; Sachdeva KS
Indian J Med Ethics; 2020; V(1):53-56. PubMed ID: 32103799
[TBL] [Abstract][Full Text] [Related]
3. Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question".
Rajpal S; Arora VK
Indian J Tuberc; 2020 Dec; 67(4S):S43-S47. PubMed ID: 33308671
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis control in India: Refocus on nutrition.
Shaji B; Arun Thomas ET; Sasidharan PK
Indian J Tuberc; 2019 Jan; 66(1):26-29. PubMed ID: 30797277
[TBL] [Abstract][Full Text] [Related]
5. Awareness and perspectives on expansion of latent TB management among public-sector physicians and medical trainees in Delhi, India.
Sharma N; Basu S; Chopra KK; Sharma P
Indian J Tuberc; 2020 Apr; 67(2):208-212. PubMed ID: 32553313
[TBL] [Abstract][Full Text] [Related]
6. Latent TB in Indian pediatric population: An update on evidence gaps and research needs.
Surve S; Naukariya K; Shah I
Indian J Tuberc; 2023; 70 Suppl 1():S8-S13. PubMed ID: 38110266
[TBL] [Abstract][Full Text] [Related]
7. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
[No Abstract] [Full Text] [Related]
8. Tuberculosis elimination and the challenge of latent tuberculosis.
Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
[TBL] [Abstract][Full Text] [Related]
9. Latent tuberculosis infection: Opportunities and challenges.
Chee CBE; Reves R; Zhang Y; Belknap R
Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Latent Tuberculosis Infection: Updates.
Swain S; Kumar A; Vishwakarma VK; Aayilliath K A; Mittal A; Wig N
Infect Disord Drug Targets; 2024; 24(4):12-19. PubMed ID: 38031772
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges.
Paton NI; Borand L; Benedicto J; Kyi MM; Mahmud AM; Norazmi MN; Sharma N; Chuchottaworn C; Huang YW; Kaswandani N; Le Van H; Lui GCY; Mao TE
Int J Infect Dis; 2019 Oct; 87():21-29. PubMed ID: 31301458
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis and biologics in rheumatology: A special situation.
Handa R; Upadhyaya S; Kapoor S; Jois R; Pandey BD; Bhatnagar AK; Khanna A; Goyal V; Kumar K
Int J Rheum Dis; 2017 Oct; 20(10):1313-1325. PubMed ID: 28730751
[TBL] [Abstract][Full Text] [Related]
13. Malnutrition and Associated Disorders in Tuberculosis and Its Therapy.
Martin SJ; Sabina EP
J Diet Suppl; 2019; 16(5):602-610. PubMed ID: 29958051
[TBL] [Abstract][Full Text] [Related]
14. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
[TBL] [Abstract][Full Text] [Related]
15. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association.
Cole B; Nilsen DM; Will L; Etkind SC; Burgos M; Chorba T
MMWR Recomm Rep; 2020 Jul; 69(7):1-27. PubMed ID: 32730235
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nutritional status and diabetes on active and latent tuberculosis: a cross-sectional analysis.
Kubiak RW; Sarkar S; Horsburgh CR; Roy G; Kratz M; Reshma A; Knudsen S; Salgame P; Ellner JJ; Drain PK; Hochberg NS
BMC Infect Dis; 2019 Jul; 19(1):627. PubMed ID: 31311495
[TBL] [Abstract][Full Text] [Related]
17. Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
Degeling C; Denholm J; Mason P; Kerridge I; Dawson A
J Med Ethics; 2017 Sep; 43(9):632-636. PubMed ID: 28143943
[TBL] [Abstract][Full Text] [Related]
18. Latent tuberculosis infection (LTBI): a real host defence or a permanent threat?
Sanduzzi A; Ponticiello A; Bocchino M; Perna F; Vatrella A
Infez Med; 2016 Sep; 24(3):179-82. PubMed ID: 27668896
[TBL] [Abstract][Full Text] [Related]
19. Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country: The importance of Mantoux and Quantiferon-TB Gold tests.
Malaviya AN; Aggarwal VK; Rawat R; Baghel S; Thakran R; Zaheer Q; Garg S; Kapoor S
Int J Rheum Dis; 2018 Aug; 21(8):1563-1571. PubMed ID: 29345081
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
